{"id":229981,"title":"Notice to stakeholders: Health Canada's expectations regarding risk-management measures for clinical trials involving psychedelic-assisted psychotherapy - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T08:11:25.689000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/expectations-risk-management-measures-clinical-trials-psychedelic-assisted-psychotherapy.html?wbdisable=true","snippet":"Notice to stakeholders: Health Canada's expectations regarding risk-management measures for clinical trials involving psychedelic-assisted psychotherapy - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search…","rawSnapshotUrl":"/api/snapshots/raw/229981","browseUrl":"https://replay.healtharchive.ca/job-1/20250419081125/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/expectations-risk-management-measures-clinical-trials-psychedelic-assisted-psychotherapy.html?wbdisable=true#ha_snapshot=229981","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}